Publication | Open Access
Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial
27
Citations
24
References
2015
Year
ISRCTN 32207582.
| Year | Citations | |
|---|---|---|
Page 1
Page 1